Analysts expect Evofem Biosciences, Inc. to report revenue of 30.73 M for Q1 25, against a range of 29.76 M to 31.70 M. The most recent reported quarter, Q2 26, came in at 2.63 M, a 94.4% miss against the 47.26 M consensus.
| Metric | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 5.81 M | 2.46 M | 5.11 M | 4.84 M | 3.60 M | 4.16 M | 4.50 M | 7.10 M | - | 4.83 M | 4.95 M | 9.56 M | 899,000.00 | 2.63 M | - | - | - | - | - | - |
| High Estimate | 14.17 M | 18.99 M | 24.73 M | 5.16 M | - | - | - | - | 31.70 M | 37.23 M | 54.74 M | 82.73 M | 41.07 M | 51.96 M | 66.83 M | 100.51 M | 41.62 M | 63.36 M | 74.95 M | 117.95 M |
| Low Estimate | 12.28 M | 16.89 M | 20.79 M | 4.80 M | - | - | - | - | 29.76 M | 33.42 M | 45.45 M | 71.01 M | 37.46 M | 42.57 M | 57.65 M | 91.47 M | 38.46 M | 57.32 M | 63.18 M | 101.12 M |
| Consensus Estimate | 13.22 M | 17.94 M | 22.76 M | 4.98 M | - | - | - | - | 30.73 M | 35.33 M | 50.09 M | 76.87 M | 39.26 M | 47.26 M | 62.24 M | 95.99 M | 40.04 M | 60.34 M | 69.07 M | 109.54 M |
Analysts expect Evofem Biosciences, Inc. to report earnings per share of 5.60 for Q1 25, against a range of 5.30 to 5.90. The most recent reported quarter, Q4 24, came in at -0.03.
| Metric | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.85 | -5.43 | 0.10 | -0.44 | -0.16 | 0.00 | -0.02 | -0.03 | - | - | - | - | - | - | - | - | ||||
| High Estimate | -13.37 | -8.91 | -6.67 | -0.56 | - | - | - | - | 5.90 | 7.65 | 8.63 | 7.50 | 13.93 | 15.60 | 17.30 | 16.59 | ||||
| Low Estimate | -15.49 | -10.41 | -7.47 | -0.60 | - | - | - | - | 5.30 | 7.07 | 7.53 | 6.76 | 12.13 | 14.26 | 15.58 | 15.31 | ||||
| Consensus Estimate | -14.43 | -9.66 | -7.07 | -0.58 | - | - | - | - | 5.60 | 7.36 | 8.08 | 7.13 | 13.03 | 14.93 | 16.44 | 15.95 |
Pull Wall Street consensus for Evofem Biosciences, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=EVFM&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "EVFM", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=EVFM&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();